AzTrials
AzTrials

Achilles Tendon RuptureNCT02015364

Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization

A study of Achilles Tendon Rupture and Deep Vein Thrombosis, run by Hvidovre University Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study objectives To investigate if early controlled mobilization of the ankle in week 3 to 8 affects the functional outcome and patient reported outcome after treatment of acute Achilles tendon rupture. Type of study Randomized, controlled trial (RCT). 130 patients will be included. Time schedule Begins January 2014. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Achilles Tendon Rupture, Deep Vein Thrombosis
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteDenmark
Study dates
Feb 2014to Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • rupture happened within 5 days.
  • Age 18-70 years.
  • The patient must be expected to be able to attend rehabilitation and post-examinations.
  • The patient must be able to speak and understand Danish.
  • The patient must be able to give informed consent.

Who cannot join

  • Former rupture of one or both Achilles tendon(s).
  • Previous surgery on the Achilles tendon.
  • Fluoroquinolone treatment within the last 6 months.
  • Tendinosis treated with corticosteroids (tablets or injections) within the last 6 months.
  • The patient has been diagnosed with arterial insufficiency in the legs.
  • Terminal illness or severe medical illness: ASA score higher than or equal to 3.
  • The space between the rupture and the calcaneus is less than 1cm.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Copenhagen University Hospital Hvidovre

    Hvidovre, Copenhagen, 2650

Other trials in Denmark

About this study

Official title: Non-operative Treatment of Acute Achilles Tendon Rupture, Early Controlled Mobilization Compared With Immobilization: A Blinded Randomized, Controlled Trial

Study objectives To investigate if early controlled mobilization of the ankle in week 3 to 8 affects the functional outcome and patient reported outcome after treatment of acute Achilles tendon rupture.

Type of study

Read more

Randomized, controlled trial (RCT). 130 patients will be included.

Time schedule

Begins January 2014. Study period is 4-5 years; recruitment is expected to span 2 years

Setup At Copenhagen University Hospital Hvidovre the majority of patients with acute ATR are treated non-operatively. A cast is applied in the emergency room. After 2 weeks the bandage is changed to a removable orthosis and full weight bearing is allowed.

Patients who choose to participate in the trial will - through randomisation - be placed in one of the two groups:

  1. The intervention group: Must perform controlled mobilization-exercises from the beginning of week 3.
  2. The control group: In line with the current treatment regimen the patients must keep the boot on at all times and they are not allowed to move the ankle.

Treatment protocol for the two groups is similar concerning orthose, removal of wedges and weight-bearing. The only difference is that patients in the intervention group are instructed to do ankle exercise.

Post-examinations in relation to the study Follow-up is done at 8 and 16 weeks plus 6 and 12 months. The study's primary endpoint is at the 12 month mark.

Population Patients who are treated for acute Achilles tendon rupture at Copenhagen University Hospital Hvidovre. Patients who fulfil the inclusion criteria but do not wish to participate are treated according the standard regimen (non-operatively without early controlled movement of the ankle joint).

Number of patients 65 patients will be included in each group (a 130 patients in total).

Read the detailed description

Study objectives To investigate if early controlled mobilization of the ankle in week 3 to 8 affects the functional outcome and patient reported outcome after treatment of acute Achilles tendon rupture.

Study Design Type of study The study is performed as a single-blinded, randomized, controlled trial (RCT). The randomisation is computer based; opaque envelopes are used. In total 130 patients will be included.

Time schedule Recruitment of patients for the study begins 1st of November 2013. The expected study period is 4-5 years; the recruitment itself is expected to span 2 years, provided that an average of 6 patients is included per month.

Method Setup At Copenhagen University Hospital Hvidovre the majority of patients with acute ATR are treated non-operatively. A cast is applied in the emergency room. After 2 weeks the bandage is changed to a removable orthosis and full weight bearing is allowed.

Patients who choose to participate in the trial will - through randomisation - be placed in one of the two groups:

  1. The intervention group: Must perform controlled mobilization-exercises from the beginning of week 3.
  2. The control group: In line with the current treatment regimen the patients must keep the boot on at all times and they are not allowed to move the ankle.

Treatment protocol for the two groups is similar concerning orthose, removal of wedges and weight-bearing. The only difference is that patients in the intervention group are instructed to do ankle exercise.

Compliance

The following measures will be taken to ensure compliance within the groups:

  1. The intervention group: The patients will be equipped with training diaries in which they will record their training for each of the five daily training sessions.
  2. The control group: The orthosis will be sealed. If the boot is removed it can be registered. Blinding The doctors and physical therapists who will conduct the follow-up will be blinded to the intervention. This is ensured as a Project Nurse will be in charge of the randomisation. The patients will be given a direct phone number for the Project Nurse, as he/she will be in charge of treatment related question and enquiries during the intervention period. Potential medical queries will be discussed with one of the affiliated doctors. Post-examinations in relation to the study Follow-up is done at 8 and 16 weeks plus 6 and 12 months. The study's primary endpoint is at the 12 month mark. Population Patients who are treated for acute Achilles tendon rupture at Copenhagen University Hospital Hvidovre. Patients who fulfil the inclusion criteria but do not wish to participate are treated according the standard regimen (non-operatively without early controlled movement of the ankle joint). Number of patients 65 patients will be included in each group (a 130 patients in total). The sample size calculation is based on a clinical relevant difference of 10 point in ATRS, a standard deviation (SD) of 16 and power of 0.90 (two sided). In a previous material, with a fully comparable population, we found a SD of 16 points at the 1 year post-examination. 54 patients is required in each group; due to the risk of drop out 65 patients will be included in each group. Inclusion criteria
  • Age 18-70 years.
  • The patient must be expected to be able to attend rehabilitation and post-examinations.
  • The patient must be able to speak and understand Danish.
  • The patient must be able to give informed consent. Exclusion criteria
  • Former rupture of one or both Achilles tendon(s).
  • Previous surgery on the Achilles tendon.
  • Fluoroquinolone treatment within the last 6 months.
  • Tendinosis treated with corticosteroids (tablets or injections) within the last 6 months.
  • The patient has been diagnosed with arterial insufficiency in the legs.
  • Terminal illness or severe medical illness: ASA score higher than or equal to 3.
  • The space between the rupture and the calcaneus is less than 1cm. Data Registration All relevant data is recorded in a specially designed database. The data registration will be reported to the Danish Data Protection Agency. Primary endpoint The primary endpoint is evaluated at 12 month. ATRS: Achilles tendon Total Rupture Score 25 A patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture. Secondary endpoints Heel-rise work test: Endurance test where the patient stands on one leg and lifts the heel up and down until exhaustion. The number and the height of the heel-rises are counted and measured. The results are then compared to the weight of the patient and the total work is estimated. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used 25. Single heel-rise test: The patient stands with the foot in neutral position. It is recorded whether the patient is able to make a single heel-rise on the injured leg. The heel-rise is acknowledged if the heel can be lifted at least 2 cm with stretched knee. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used 26. Ultrasound: The length between the calcaneus and the distal tip of the medial head of the gastrocnemius muscle. Amlangs ultrasound classification 27. Cost effectiveness analysis: A cost effectiveness analysis will be performed comparing the two treatment protocols. DVT screening: Ultra sound for deep Vein Thrombosis (DVT) will be performed after 2 and 8 weeks. Perimeter of calf: The perimeter of the calf is measured at the widest point on the injured side after 16 weeks. The distance from this point to lower edge of the patella is measured in centimeters. The distance is used to measure the perimeter on the healthy leg and for all subsequent measurements during the trial. Re-ruptur (RR): It is registered if the tendon re-ruptures during the trial period. Work: Hard physical labour involving heavy lifting, climbing stairs or climbing the ladder. E.g. bricklayer, paviour, carpenter, dustman, mailman. Moderate physical work that involves a lot of walking. E.g. salesperson, shop assistant, nurse. Light physical work which only involves light walking. E.g. office work Return to work: It is recorded how many days have passed before work is resumed part-time and full-time. Sport: Does the patient do sports? If yes, what kind, how many hours per week on average and at what level (professional, amateur, exerciser). Return to sport: It is recorded how many days have passed before sport activities are resumed and how many days have passed before sport activities reach a premorbid level. Health information: Former disease in or around the Achilles tendon, rheumatic disease, dominant leg. Other data: Age, Cpr.nr., other master data necessary to identify and call back the patient for post-examinations. The study is carried out in accordance with the principles of the Helsinki Declaration. Patients are covered by the patient insurance of Copenhagen University Hospital Hvidovre. The protocol as well as the patient information and declaration of consent must be approved by the National Committee on Health Research Ethics before inclusion of patients will begin. The project manager is responsible for informing the National Committee on Health Research Ethics of any critical adverse event and/or major changes of the protocol. All correspondence will be filed by the project manager. Declaration of consent All patients will receive verbal and written information concerning the study. The inclusion will take place after a declaration of consent has been obtained. It is the responsibility of the investigators to provide patients with comprehensive verbal and written information concerning the course of the study, purpose, potential risks and benefits. Statistics The two groups are described descriptively regarding demographic parameters as well as primary and secondary endpoints as described above in the paragraph "Data registration". Comparison of the primary and secondary outcomes of both groups is done by using relevant statistics according to the characteristics of the variables and if necessary the normal distribution. The change of the outcomes over a period of time is described within each group. The research group The study is carried out as collaboration between the research unit, Clinical Orthopaedic Research Hvidovre (www.corh.dk) and the Department of Physical- and Occupational Therapy, both at Copenhagen University Hospital Hvidovre. Data analysis and writing articles The data analysis and the drawing up of articles are done by the project manager and last-author. The project group is regularly involved in the process. Economic conditions The study is funded by the Department of Orthopaedic Surgery and the Department of Physiotherapy, Copenhagen University Hospital Hvidovre. The project group has independently initiated the study. Patients will not receive any fees for participation. Publication It is expected that the study will be published in an international, high-impact journal. We will furthermore seek to have the results presented at both national and international medical conventions. The results will also be published online and in other relevant media.
Being tested
Controlled early mobilization
Keywords
Achilles tendon, Rupture, Rehabilitation, Dynamic rehabilitation
Medical subject headings
Venous Thrombosis, Rupture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Controlled early mobilizationProcedure or surgery

    1. The intervention group: Must perform controlled mobilization-exercises from the beginning of week 3 - 8.
Study groups in NCT02015364
Study groupRoleWhat they receive
Controlled early mobilizationExperimentalThe intervention group: Must perform controlled mobilization-exercises from the beginning of week 3 to 8
Receives: Procedure: Controlled early mobilization
ImmobilizationNo interventionThe control group: In line with the current treatment regimen the patients must keep the boot on at all times and they are not allowed to move the ankle.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Achilles tendon Total Rupture Score

    A patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture.

    Measured: 12 months

Secondary outcomes (25)
  1. Achilles tendon Total Rupture Score

    A patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture.

    Measured: 6 months

  2. Achilles tendon Total Rupture Score

    A patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture.

    Measured: 24 months

  3. Heel-rise work test

    Endurance test where the patient stands on one leg and lifts the heel up and down until exhaustion. The number and the height of the heel-rises are counted and measured. The results are then compared to the weight of the patient and the total work is estimated. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used

    Measured: 6 months

  4. Heel-rise work test

    Endurance test where the patient stands on one leg and lifts the heel up and down until exhaustion. The number and the height of the heel-rises are counted and measured. The results are then compared to the weight of the patient and the total work is estimated. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used

    Measured: 12 months

  5. Single heel-rise test

    The patient stands with the foot in 10 degrees of dorsiflexion. It is recorded whether the patient is able to make a single heel-rise on the injured leg. The heel-rise is acknowledged if the heel can be lifted at least 2 cm with stretched knee. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used

    Measured: 6 months

  6. Single heel-rise test

    The patient stands with the foot in 10 degrees of dorsiflexion. It is recorded whether the patient is able to make a single heel-rise on the injured leg. The heel-rise is acknowledged if the heel can be lifted at least 2 cm with stretched knee. The MuscleLab ® (Ergo Test Technology, Oslo, Norway) measurement system is used

    Measured: 12 months

  7. Ultrasound length measure

    The length between the calcaneus and the distal tip of the medial head of the gastrocnemius muscle.

    Measured: 6 months

  8. Ultrasound length measure

    The length between the calcaneus and the distal tip of the medial head of the gastrocnemius muscle.

    Measured: 12 months

  9. Cost effectiveness analysis

    A cost effectiveness analysis will be performed comparing the two treatment protocols.

    Measured: 12 months

  10. Re-rupture

    Measured: 12 months

  11. Re-rupture

    Measured: 24 months

  12. Perimeter of calf

    Measured: 6 months

  13. Perimeter of calf

    Measured: 12 months

  14. Return to work

    Measured: 6 months

  15. Return to work

    Measured: 12 months

  16. Return to work

    Measured: 24 months

  17. Return to sports

    Measured: 6 months

  18. Return to sports

    Measured: 12 months

  19. Return to sports

    Measured: 24 months

  20. Achilles Tendon Resting Angle (ATRA)

    Measured: 6 months

  21. Achilles Tendon Resting Angle (ATRA)

    Measured: 12 months

  22. Achilles Tendon Length Measure (ATLM)

    Measured: 6 months

  23. Achilles Tendon Length Measure (ATLM)

    Measured: 12 months

  24. Plantarflexion power

    Plantarflexion power is measured with a hand held dynamometer fixed to the examination bed with a strong Velcro band.

    Measured: 6 months

  25. Plantarflexion power

    Plantarflexion power is measured with a hand held dynamometer fixed to the examination bed with a strong Velcro band.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2013 (estimated)
  2. Study startFeb 2014
  3. Primary completionFeb 2018
  4. Study completionFeb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02015364
Sponsor's protocol ID
ATR_Denmark_2014
Status last verified
Aug 2019
First submitted
13 Dec 2013
Last updated
13 Aug 2019
Results posted
No
Data monitoring committee
No

Publications

  • Barfod KW, Nielsen EG, Olsen BH, Vinicoff PG, Troelsen A, Holmich P. Risk of Deep Vein Thrombosis After Acute Achilles Tendon Rupture: A Secondary Analysis of a Randomized Controlled Trial Comparing Early Controlled Motion of the Ankle Versus Immobilization. Orthop J Sports Med. 2020 Apr 28;8(4):2325967120915909. doi: 10.1177/2325967120915909. eCollection 2020 Apr.

    PubMed 32426409
  • Barfod KW, Hansen MS, Holmich P, Kristensen MT, Troelsen A. Efficacy of early controlled motion of the ankle compared with immobilisation in non-operative treatment of patients with an acute Achilles tendon rupture: an assessor-blinded, randomised controlled trial. Br J Sports Med. 2020 Jun;54(12):719-724. doi: 10.1136/bjsports-2019-100709. Epub 2019 Oct 9.

    PubMed 31597624
  • Barfod KW, Hansen MS, Holmich P, Troelsen A, Kristensen MT. Efficacy of early controlled motion of the ankle compared with no motion after non-operative treatment of an acute Achilles tendon rupture: study protocol for a randomized controlled trial. Trials. 2016 Nov 29;17(1):564. doi: 10.1186/s13063-016-1697-2.

    PubMed 27894329

Questions about this trial

What is this clinical trial studying?

A study of Achilles Tendon Rupture and Deep Vein Thrombosis, run by Hvidovre University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Achilles tendon Total Rupture Score (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02015364, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2019; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in